Issue
Alert me when new journal issues are available via or via
=free full text
An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation Oncology Robert D. Timmerman pages 215-222 Full Text | Full-Text PDF (123 KB)
Clinical Experience Shows That Catastrophic Late Effects Associated With Ablative Fractionation Can Be Avoided by Technological Innovation Brian Kavanagh pages 223-228 Abstract | Full Text | Full-Text PDF (105 KB)
Some Cases of Severe Normal Tissue Toxicity Can Be Anticipated With Ablated Fractionated Radiation With Appropriate Long-term Follow-up Christopher Dolinsky, Eli Glatstein pages 229-233 Abstract | Full Text | Full-Text PDF (104 KB)
The Linear-Quadratic Model Is an Appropriate Methodology for Determining Isoeffective Doses at Large Doses Per Fraction David J. Brenner pages 234-239 Abstract | Full Text | Full-Text PDF (301 KB)
The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery John P. Kirkpatrick, Jeffrey J. Meyer, Lawrence B. Marks pages 240-243 Abstract | Full Text | Full-Text PDF (120 KB)
Exploring the Possibility of Unique Molecular, Biological, and Tissue Effects With Hypofractionated Radiotherapy Michael Story, Reinhard Kodym, Debabrata Saha pages 244-248 Abstract | Full Text | Full-Text PDF (94 KB)
Rationale, Conduct, and Outcome Using Hypofractionated Radiotherapy in Prostate Cancer Mark Ritter pages 249-256 Abstract | Full Text | Full-Text PDF (536 KB)
Clinical Experience Using Hypofractionated Radiation Schedules in Breast Cancer Timothy J. Whelan, Do-Hoon Kim, Jonathan Sussman pages 257-264 Abstract | Full Text | Full-Text PDF (135 KB)
The Implementation of Ablative Hypofractionated Radiotherapy for Stereotactic Treatments in the Brain and Body: Observations on Efficacy and Toxicity in Clinical Practice Lucien A. Nedzi pages 265-272 Abstract | Full Text | Full-Text PDF (139 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
